CV THERAPEUTICS INC·4

Feb 9, 4:42 PM ET

BLACKBURN BRENT K 4

4 · CV THERAPEUTICS INC · Filed Feb 9, 2009

Insider Transaction Report

Form 4
Period: 2009-02-06
BLACKBURN BRENT K
SVP, Drug Discovery & Dev
Transactions
  • Sale

    Common Stock

    2009-02-06$15.50/sh1,500$23,25029,561 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    6,730.908
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2007 and amended December 10, 2008.
  • [F2]Shares held in the Reporting Person's name by the Issuer's 401(k) plan. Includes Company 401(k) match of 1,679 shares of common stock to the Reporting Person on January 7, 2009.

Documents

1 file
  • 4
    rrd232340.xmlPrimary

    BLACKBURN FEBRUARY 6, 2009 STOCK SALE PER AMENDED 10B5-1 PLAN